Altogen Biosystems

PRODUCTS

CUSTOM SERVICES

CUSTOMER SUPPORT

CONTACT US

 

 

 

 

 
Focus Areas
Transfection Resource
How to Order
Technical Support
shopping cart (cart:0 item)

 

 

 

 

 

 

PGHAM Transfection Reagent  

Catalog # 3233 - 0.5 mL        $ 145.00

Catalog # 3234 - 1.5 mL        $ 336.00

Transfection reagent for PGHAM cells

  • Protocols provided for transfection of siRNA and microRNA
  • High transfection efficiency
  • Kit includes Transfection Enhancer reagent and recommended transfection protocols
  • Compatible with transfection in any plate format
  • Optimized for PGHAM (hamster Pancreatic Carcinoma Cells)
  • Optimized transfection protocols are adapted for use with both standard & reverse transfection methods
  • Developed and manufactured by Altogen Biosystems
  • Transfection Efficiency:
    Reagent exhibits at least 90% transfection efficiency of siRNA delivery. Transfection efficiency was determined by fluorescent microscopy and real-time RT-PCR.

    Transfection Protocol:
    Transfection protocols are provided with the purchase of the reagent.

Transfection Resource

Visit Altogen Biosystems Transfection Resource: RNAi applications (siRNA transfection, microRNA transfection, plasmid DNA transfection), stable and transient DNA transfection, delivery methods, electroporation, microinjection, dendrimer-based, non-viral and virus-mediated gene delivery, liposome and non-liposomal reagents. Transfection of cancer cell lines vs primary cultures. RNA Interference as a research tool for gene expression studies, gene silencing in neuronal cells, RNAi therapeutics and In Vivo Transfection Reagents from Altogen Biosystems.

PGHAM (hamster Pancreatic Carcinoma Cells)

PGHAM-1 cell line was derived from an N-nitrosobis(2-oxopropyl)amine (BOP)-induced pancreatic tumor in a Syrian hamster. The tumors were minced and subcutaneously transplanted with a trocar into the interscapular area of untreated 5-week-old hamsters. The recipient hamsters were killed at 6–8 weeks after transplantation, and a portion of the tumor tissue was serially transplanted. After subcutaneous transplantation 8 times, the tumor was extracted under germ-free conditions, Cells that had been maintained in culture for 60 passages and had become established as a cell line were named PGHAM-1 The tumor showed a striking similarity to human pancreatic ductal adenocarcinoma and had a moderate to well-differentiated histology. PGHAM-1 contains a K-ras point mutation at codon 12, one of the most frequent types of K-ras mutation in human pancreatic cancers. Researchers have frequently used PGHAM-1 in experiments because of their cells’ rapid growth and a high rate of metastasis.

Transfection Resource

siRNA Transfection || Transfection Methods || Stable Transfection || RNAi || siRNA Library Screening || RNAi Therapeutics || Cell Transfection || In Vivo Transfection Reagents || Cell Line Specific Transfection Reagents

Featured Products

In Vivo Transfection Reagents || Fibroblast Cells Transfection Reagent || Astrocyte Cells Transfection Reagent || HEK-293 Transfection Reagent || MEF Transfection Reagent || HepG2 Transfection Reagent || CHO Reagent || MDA-MB Transfection Reagent || Cos7 Transfection Reagent || A549 Transfection Reagent || NIH3T3 Reagent || HUVEC Transfection Reagent || LNCaP Transfection Reagent || MCF-7 Reagent || PC-12 Reagent

Altogen Research Services

Altogen Custom Services provide specialized biotechnology and pharmaceutical services, including - generation of stable cell lines, RNA Interference (RNAi) services, assay development, screening and transfection services. Generation of stably-expressing cancer cell lines and primary cells can be very expensive and time-consuming. Altogen Services offers generation of stable cell lines by transforming the cell line of choice to stably express gene of interest or shRNA-encoding construct. Cloning and shRNA expression services are available.

 

 

 

Copyright ©2007 Altogen Biosystems. All rights reserved.